Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Evercore ISI Starts Arcellx Inc. (ACLX) at Outperform
-
Evercore ISI Starts Neurocrine Bio. (NBIX) at Outperform
-
Goldman Sachs Upgrades Fulcrum Therapeutics (FULC) to Buy
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Akamai Technologies (AKAM)
-
-
-
-
-
-
-
CF Industries (CF) PT Lowered to $73 at Stifel
-
-
-
-
-
-
-
Charles River Labs (CRL) PT Lowered to $228 at TD Cowen
-
-
-
-
-
-
-
MasTec (MTZ) PT Raised to $120 at KeyBanc
-
-
-
-
-
-
-
Banc of California (BANC) PT Lowered to $19 at Piper Sandler
-
-
-
-
-
-
-
Pacific Biosciences of California (PACB) PT Lowered to $2 at Piper Sandler
-
-
-
-
-
356,303 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.